{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Titan Biotech Ltd
Titan Biotech Ltd is Rated Buy by MarketsMOJO
Titan Biotech Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 22 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Titan Biotech Falls 18.45% Despite Record Highs: 4 Key Factors Driving the Decline
Titan Biotech Ltd experienced a sharp decline of 18.45% over the week ending 10 April 2026, closing at Rs.431.55 from Rs.529.20, contrasting sharply with the Sensex’s 5.34% gain during the same period. Despite reaching new 52-week and all-time highs early in the week, the stock faced sustained selling pressure amid mixed market signals and valuation concerns.
Titan Biotech Ltd is Rated Buy by MarketsMOJO
Titan Biotech Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 April 2026, providing investors with the most recent insights into its performance and outlook.
Broad-Based Technical Strength Lifts Titan Biotech Ltd to 52-Week High of Rs 555.65
Surging to an intraday peak of Rs 555.65 on 7 Apr 2026, Titan Biotech Ltd has marked a remarkable milestone by hitting a fresh 52-week high. This rally, driven by a confluence of robust technical indicators and sustained price momentum, stands out amid a broader market backdrop where the Sensex trades near its 52-week low.
Titan Biotech Ltd Hits All-Time High of Rs 555.65 as Momentum Builds Across Timeframes
Extending its winning streak to eight consecutive sessions, Titan Biotech Ltd surged 5% today to touch a fresh all-time high of Rs 555.65, significantly outpacing the Sensex which declined 0.41% in the same session.
Broad-Based Technical Strength Lifts Titan Biotech Ltd to 52-Week High of Rs 529.15
Surging past its previous peaks, Titan Biotech Ltd touched a fresh 52-week high of Rs 529.15 on 6 Apr 2026, marking a remarkable rally from its 52-week low of Rs 74.73. This milestone caps a seven-day winning streak that has propelled the stock up by 36.55%, underscoring a powerful momentum that stands out amid a broadly subdued market backdrop.
Titan Biotech Ltd Hits All-Time High of Rs 529.15 as Momentum Builds Across Timeframes
Titan Biotech Ltd, a prominent player in the specialty chemicals sector, achieved a significant milestone on 6 April 2026 as its stock price surged to an all-time high of Rs.529.15. This landmark event reflects the company’s robust performance and sustained upward momentum in the market.
Titan Biotech Gains 15.57%: 7 Key Factors Driving the Surge
Titan Biotech Ltd delivered a strong weekly performance, rising 15.57% from Rs.436.10 to Rs.504.00 between 30 March and 2 April 2026, significantly outperforming the Sensex which declined by 0.29% over the same period. The stock hit multiple new 52-week and all-time highs amid robust quarterly results, sustained technical momentum, and sectoral resilience, despite a challenging broader market environment.
435.8% Stock Return, 20.9% Profit Growth: What’s Driving Titan Biotech Ltd’s Multibagger Rerating?
A 435.8% stock return in one year. A 20.9% growth in net profit over the same period. The gap between those two numbers — roughly 415 percentage points — is driven entirely by the market's willingness to pay more for each rupee of Titan Biotech Ltd's earnings. That willingness is the story.
Broad-Based Technical Strength Lifts Titan Biotech Ltd to 52-Week High of Rs 502.4
Surging from a 52-week low of Rs 74.73 to a fresh high of Rs 502.4 on 2 Apr 2026, Titan Biotech Ltd has delivered an extraordinary 403.68% return over the past year, defying the broader market’s downward trend. This milestone caps a remarkable rally fuelled by a confluence of strong technical indicators and sustained price momentum.
Titan Biotech Ltd Hits All-Time High of Rs 502.4 as Momentum Builds Across Timeframes
Extending its winning streak to six consecutive sessions, Titan Biotech Ltd surged to a fresh all-time high of Rs 502.4 on 2 Apr 2026, outperforming both its sector and the broader market by a wide margin.
Broad-Based Technical Strength Lifts Titan Biotech Ltd to 52-Week High of Rs 480.55
Surging past Rs 480.55, Titan Biotech Ltd has reached a new 52-week high, marking a remarkable ascent from its low of Rs 74.73 just a year ago. This extraordinary rally, delivering over 425% returns, is underpinned by a confluence of robust technical indicators and sustained price momentum that have propelled the stock well beyond its peers and the broader market.
Titan Biotech Ltd Hits All-Time High of Rs 480.55 as Momentum Builds Across Timeframes
Titan Biotech Ltd, a micro-cap company in the Specialty Chemicals sector, reached a new all-time high price of Rs.480.55 on 1 April 2026, marking a significant milestone in its market journey. The stock outperformed both its sector and the broader Sensex index, reflecting a strong upward momentum supported by robust financial and technical indicators.
Titan Biotech Ltd is Rated Buy by MarketsMOJO
Titan Biotech Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 March 2026, providing investors with the most recent and relevant data to assess the stock’s potential.
Broad-Based Technical Strength Lifts Titan Biotech Ltd to 52-Week High of Rs 457.9
Surging to a fresh 52-week high of Rs 457.9 on 30 Mar 2026, Titan Biotech Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market despite a challenging environment for the Sensex. This milestone caps a four-day winning streak that has propelled the stock up by 18.2%, underscoring the strength of its technical setup.
Titan Biotech Ltd Hits All-Time High of Rs 457.90 as Momentum Builds Across Timeframes
Extending a four-day winning streak, Titan Biotech Ltd surged to a fresh all-time high of Rs 457.90 on 30 Mar 2026, outperforming its sector and the broader market by a wide margin.
Titan Biotech Gains 7.60%: 4 Key Factors Driving the Week’s Rally
Titan Biotech Ltd delivered a robust weekly performance from 16 to 20 March 2026, gaining 7.60% against the Sensex’s decline of 0.28%. The stock demonstrated resilience and strong momentum, reaching new all-time and 52-week highs amid positive quarterly financial results and technical strength. Despite a challenging broader market, Titan Biotech outperformed consistently, supported by record sales, profit growth, and an upgraded analyst rating.
Titan Biotech Gains 9.97%: 4 Key Factors Driving the Week’s Rally
Titan Biotech Ltd delivered a strong weekly performance from 23 to 27 March 2026, rising 9.97% from Rs.396.55 to Rs.436.10, significantly outperforming the Sensex which declined 1.46% over the same period. The stock demonstrated robust momentum with multiple new 52-week and all-time highs, supported by impressive quarterly financial results and positive technical indicators despite a mixed broader market environment.
Broad-Based Technical Strength Lifts Titan Biotech Ltd to 52-Week High of Rs 436.6
With a remarkable surge to Rs 436.6 on 27 Mar 2026, Titan Biotech Ltd has reached a new 52-week high, extending its impressive rally that has delivered over 413% returns in the past year. This milestone comes amid a backdrop of broad technical alignment and sustained price momentum, setting the stock apart in a market where the Sensex is trading near its 52-week low.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
